IL95663A0 - Stabilized aqueous formulations of small peptides - Google Patents
Stabilized aqueous formulations of small peptidesInfo
- Publication number
- IL95663A0 IL95663A0 IL95663A IL9566390A IL95663A0 IL 95663 A0 IL95663 A0 IL 95663A0 IL 95663 A IL95663 A IL 95663A IL 9566390 A IL9566390 A IL 9566390A IL 95663 A0 IL95663 A0 IL 95663A0
- Authority
- IL
- Israel
- Prior art keywords
- small peptides
- aqueous formulations
- stabilized aqueous
- stabilized
- formulations
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
- A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US41384189A | 1989-09-28 | 1989-09-28 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL95663A0 true IL95663A0 (en) | 1991-06-30 |
Family
ID=23638883
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL95663A IL95663A0 (en) | 1989-09-28 | 1990-09-12 | Stabilized aqueous formulations of small peptides |
Country Status (14)
| Country | Link |
|---|---|
| EP (1) | EP0420649A3 (xx) |
| JP (1) | JPH04502017A (xx) |
| AU (1) | AU6446790A (xx) |
| BR (1) | BR9006934A (xx) |
| CA (1) | CA2026149A1 (xx) |
| DD (1) | DD298053A5 (xx) |
| HU (1) | HUT59013A (xx) |
| IE (1) | IE903475A1 (xx) |
| IL (1) | IL95663A0 (xx) |
| IT (1) | IT1240314B (xx) |
| NZ (1) | NZ235324A (xx) |
| PT (1) | PT95451A (xx) |
| WO (1) | WO1991004743A1 (xx) |
| ZA (1) | ZA907492B (xx) |
Families Citing this family (28)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5036050A (en) * | 1989-01-12 | 1991-07-30 | Immunobiology Research Institute, Inc. | Compositions containing thymopentin for topical treatment of skin disorders |
| EP0689843B1 (en) * | 1993-12-17 | 2003-09-10 | Mochida Pharmaceutical Co., Ltd. | Composition containing soluble thrombomodulins |
| CA2192725C (en) | 1995-12-28 | 2004-04-20 | Kenji Tsujihara | Camptothecin derivatives |
| ES2644275T3 (es) * | 2000-08-11 | 2017-11-28 | Chugai Seiyaku Kabushiki Kaisha | Preparaciones estabilizadas que contienen anticuerpos |
| US7132100B2 (en) | 2002-06-14 | 2006-11-07 | Medimmune, Inc. | Stabilized liquid anti-RSV antibody formulations |
| US7425618B2 (en) | 2002-06-14 | 2008-09-16 | Medimmune, Inc. | Stabilized anti-respiratory syncytial virus (RSV) antibody formulations |
| US7772188B2 (en) | 2003-01-28 | 2010-08-10 | Ironwood Pharmaceuticals, Inc. | Methods and compositions for the treatment of gastrointestinal disorders |
| EP2264065B1 (en) | 2003-08-05 | 2017-03-08 | Novo Nordisk A/S | Novel insulin derivatives |
| DE102004011663B4 (de) | 2004-03-10 | 2006-04-27 | Bioceuticals Arzneimittel Ag | Erythropoietin-Flüssigformulierung |
| ES2371361T3 (es) | 2005-12-28 | 2011-12-30 | Novo Nordisk A/S | Composiciones que comprenden una insulina acilada y zinc y método de producción de dichas composiciones. |
| ES2744384T3 (es) | 2007-06-13 | 2020-02-24 | Novo Nordisk As | Formulación farmacéutica que comprende un derivado de insulina |
| CA2732892C (en) | 2008-08-15 | 2020-12-15 | Forest Laboratories Holdings Limited | Stable solid formulation of a gc-c receptor agonist polypeptide suitable for oral administration |
| RU2540922C2 (ru) | 2008-10-30 | 2015-02-10 | Ново Нордиск А/С | Лечение сахарного диабета с использованием инъекций инсулина с частотой менее одного раза в день |
| BRPI0920973B8 (pt) | 2008-11-04 | 2021-05-25 | Aska Pharm Co Ltd | composição aquosa contendo hormônio estimulanete de folículos |
| US8748573B2 (en) | 2009-08-06 | 2014-06-10 | Ironwood Pharmaceuticals, Inc. | Formulations comprising linaclotide |
| TWI505838B (zh) | 2010-01-20 | 2015-11-01 | Chugai Pharmaceutical Co Ltd | Stabilized antibody solution containing |
| AU2011218009B2 (en) | 2010-02-17 | 2016-11-03 | Ironwood Pharmaceuticals, Inc | Treatments for gastrointestinal disorders |
| PL2603232T3 (pl) | 2010-08-11 | 2020-05-18 | Ironwood Pharmaceuticals, Inc. | Stabilne formulacje linaklotydu |
| BR112013010345A2 (pt) | 2010-10-27 | 2017-07-25 | Novo Nordisk As | tratamento de diabetes melitus usando as injeções de insulina administradas com intervalos de variação da injeção |
| JP5996631B2 (ja) | 2011-04-20 | 2016-09-21 | サンド・アクチエンゲゼルシヤフト | ＴＮＦＲ：Ｆｃ融合タンパク質の安定した医薬液剤 |
| EP2776055B1 (en) | 2011-08-17 | 2016-12-14 | Ironwood Pharmaceuticals, Inc. | Treatments for gastrointestinal disorders |
| US10485869B2 (en) | 2011-10-18 | 2019-11-26 | Coherus Biosciences, Inc. | Etanercept formulations stabilized with meglumine |
| JP6220789B2 (ja) | 2011-10-18 | 2017-10-25 | コヒラス・バイオサイエンシズ・インコーポレイテッド | 糖およびポリオールの組合せによって安定化されたエタネルセプト製剤 |
| CN104902914B (zh) | 2012-09-11 | 2019-01-01 | 科荣生生物科学公司 | 高纯度和优异产量的正确折叠的依那西普 |
| US10137172B2 (en) | 2013-04-30 | 2018-11-27 | Novo Nordisk A/S | Administration regime |
| CN105012232B (zh) * | 2015-08-14 | 2017-09-05 | 北京世桥生物制药有限公司 | 一种胸腺五肽注射液及其制作方法 |
| US10335464B1 (en) | 2018-06-26 | 2019-07-02 | Novo Nordisk A/S | Device for titrating basal insulin |
| WO2023017537A1 (en) | 2021-08-12 | 2023-02-16 | Celagenex Research (India) Pvt. Ltd. | Oral algal oil based gastro-intestinal tract permeable peptide composition |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4190646A (en) * | 1975-11-11 | 1980-02-26 | Sloan-Kettering Institute For Cancer Research | Polypeptide compositions and methods |
| JPS57169425A (en) * | 1981-04-10 | 1982-10-19 | Eisai Co Ltd | Composition and method for preventing adsorption of secretin |
| EP0082481B2 (en) * | 1981-12-23 | 1990-09-12 | Schering Corporation | Stabilised alpha-interferon formulations and their preparation |
| EP0158487B1 (en) * | 1984-04-09 | 1991-08-28 | Takeda Chemical Industries, Ltd. | Stable composition of interleukin-2 |
| US4749690A (en) * | 1986-01-27 | 1988-06-07 | Ortho Pharmaceutical Corporation | Treatment of allergy with thymopentin |
| US4898826A (en) * | 1987-12-10 | 1990-02-06 | Invitron Corporation | Method to solubilize tissue plasminogen activator |
-
1990
- 1990-02-20 IT IT19421A patent/IT1240314B/it active IP Right Grant
- 1990-09-12 IL IL95663A patent/IL95663A0/xx unknown
- 1990-09-14 NZ NZ235324A patent/NZ235324A/en unknown
- 1990-09-18 BR BR909006934A patent/BR9006934A/pt unknown
- 1990-09-18 JP JP2513786A patent/JPH04502017A/ja active Pending
- 1990-09-18 WO PCT/US1990/005303 patent/WO1991004743A1/en active Application Filing
- 1990-09-18 HU HU907939A patent/HUT59013A/hu unknown
- 1990-09-18 AU AU64467/90A patent/AU6446790A/en not_active Abandoned
- 1990-09-19 ZA ZA907492A patent/ZA907492B/xx unknown
- 1990-09-25 CA CA002026149A patent/CA2026149A1/en not_active Abandoned
- 1990-09-26 DD DD90344215A patent/DD298053A5/de not_active IP Right Cessation
- 1990-09-27 PT PT95451A patent/PT95451A/pt not_active Application Discontinuation
- 1990-09-27 IE IE347590A patent/IE903475A1/en unknown
- 1990-09-27 EP EP19900310606 patent/EP0420649A3/en not_active Withdrawn
Also Published As
| Publication number | Publication date |
|---|---|
| PT95451A (pt) | 1991-05-22 |
| BR9006934A (pt) | 1991-10-22 |
| ZA907492B (en) | 1991-10-30 |
| IT9019421A0 (it) | 1990-02-20 |
| DD298053A5 (de) | 1992-02-06 |
| CA2026149A1 (en) | 1991-03-29 |
| JPH04502017A (ja) | 1992-04-09 |
| WO1991004743A1 (en) | 1991-04-18 |
| HUT59013A (en) | 1992-04-28 |
| EP0420649A3 (en) | 1991-07-31 |
| EP0420649A2 (en) | 1991-04-03 |
| IT9019421A1 (it) | 1991-03-29 |
| IE903475A1 (en) | 1991-04-10 |
| HU907939D0 (en) | 1991-08-28 |
| NZ235324A (en) | 1992-07-28 |
| AU6446790A (en) | 1991-04-28 |
| IT1240314B (it) | 1993-12-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0420649A3 (en) | Stabilized aqueous formulations of small peptides | |
| IL127770A0 (en) | Aqueous formulations of peptides | |
| HU9201966D0 (en) | An improved vaccine of meningococcus-polysaccharide conjunction | |
| EP0390930A4 (en) | Stable aqueous preparation of active vitamin d 3? | |
| GB8908250D0 (en) | Formulations | |
| IL96306A0 (en) | Preparation of deoxyfluoronucleosides | |
| SG47072A1 (en) | Water-containing external preparations | |
| ZA902519B (en) | Pharmaceutical formulations | |
| AP9000174A0 (en) | Antiparasitical formulations | |
| EP0450100A4 (en) | Physiologically active peptide | |
| GB8619182D0 (en) | Peptides & derivatives | |
| GB8916391D0 (en) | Preparation of polyacetals | |
| IL95024A0 (en) | Preparation of 2-diazo-3-trisubstituted silyloxy-3-butenoates | |
| GB8918394D0 (en) | Preparation of polyhemiacetals | |
| IL89362A0 (en) | Preparation of tetrabromotetralin | |
| CS275222B2 (en) | Analogues of deamino-vasopressin | |
| GB8808440D0 (en) | Preparation of peptide derivatives | |
| IE894144L (en) | Preparation of deglucoteicoplanin | |
| IE892415L (en) | Preparation of polyhydroxysilazanes | |
| IE893752L (en) | Preparation of n-acyl-aminomethyl-phosphonates | |
| IE892537L (en) | Preparation of trifluoroethanol. | |
| NO911988L (no) | Stabiliserte vandige formuleringer av smaa peptider. | |
| IE890708L (en) | Peptide equivalents of non-peptides | |
| GB8619181D0 (en) | Peptides & derivatives | |
| GB8828413D0 (en) | Ws7528 substance & preparation thereof |